Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference

Rhea-AI Summary

Vanda Pharmaceuticals (Nasdaq: VNDA) will participate in the J.P. Morgan Healthcare Conference in San Francisco on January 15, 2026. A corporate presentation is scheduled for 9:00 a.m. PT / 12:00 p.m. ET. The presentation will be accessible live via Vanda's website under the Investors > Recent Events section.

Investors are advised to visit the conference website at least 15 minutes early to register and install any required software. A link to the archived presentation will be available on Vanda's website for approximately 30 days after the event.

Key Figures

Conference date January 15, 2026 Scheduled J.P. Morgan Healthcare Conference presentation date

Presentation time (PT) 9:00 a.m. Scheduled corporate presentation Pacific Time

Presentation time (ET) 12:00 p.m. Scheduled corporate presentation Eastern Time

Early login window 15 minutes Suggested early login to register and install software

Archive duration 30 days Archived conference link availability on Vanda’s website

Market Reality Check

$6.60 Last Close

Volume Price at $6.6 with volume 1,684,297 vs 1,196,487 20-day average (relative volume 1.41x) ahead of this neutral conference update. normal

Technical Shares trade above the 200-day MA of $4.69, near the $6.78 52-week high and well above the $3.8092 52-week low.

Peers on Argus

VNDA was up 11.39% while peers showed mixed moves: CADL up 13.11%, LXEO up 0.51%, NMRA, OMER and TNXP down between 0.56% and 4.51%, pointing to stock-specific dynamics rather than a uniform sector move.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 04	Regulatory update	Positive	-0.8%	FDA lifted partial clinical hold on tradipitant protocol VP-VLY-686-3403.
Nov 28	Regulatory update	Positive	+1.1%	FDA expedited re-review and confirmed tradipitant PDUFA 12/30/2025.
Nov 17	Clinical data	Positive	+1.1%	Tradipitant reduced GLP-1–induced vomiting with significant p-values and good safety.
Nov 05	Conference participation	Neutral	-0.7%	Announcement of corporate presentation at Stifel 2025 Healthcare Conference.
Oct 29	Earnings and pipeline	Negative	-3.0%	Q3 loss, lowered 2025 guidance, and multiple upcoming PDUFA and BLA milestones.

Pattern Detected

Recent price reactions show positive alignment with favorable clinical and regulatory updates, while neutral conference announcements and some positive FDA developments have seen weaker or negative immediate responses.

Recent Company History

Over the last few months, VNDA reported several key milestones. On Oct 29, 2025, Q3 results showed higher sales but a $22.6M net loss and lowered 2025 guidance. Subsequent news included participation in the Stifel 2025 Healthcare Conference on Nov 12, 2025, positive tradipitant data in GLP-1–induced nausea, and regulatory updates with a Dec 30, 2025 PDUFA date. On Dec 4, 2025, the FDA lifted a partial tradipitant hold. Today’s J.P. Morgan conference participation continues this pattern of active investor and scientific engagement.

Market Pulse Summary

This announcement highlights Vanda’s participation in the J.P. Morgan Healthcare Conference on January 15, 2026, offering a platform to present its story to investors. In recent months, the company reported positive tradipitant clinical data, key FDA milestones with a Dec 30, 2025 PDUFA date, and evolving financial results. Investors tracking the name may focus on how messaging at such conferences aligns with prior regulatory updates, pipeline timelines, and recent guidance changes.

AI-generated analysis. Not financial advice.

WASHINGTON, Dec. 11, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the J.P. Morgan Healthcare Conference in San Francisco, California on Thursday, January 15, 2026.  A corporate presentation is scheduled for 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time).

The corporate presentation given at the J.P. Morgan Healthcare Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-jp-morgan-healthcare-conference-302639678.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When will Vanda Pharmaceuticals (VNDA) present at the J.P. Morgan Healthcare Conference?

Vanda will present on January 15, 2026 at 9:00 a.m. PT / 12:00 p.m. ET.

How can investors watch the VNDA presentation live on January 15, 2026?

Watch live via Vanda's website under Investors > Recent Events using the provided webcast link.

Will the VNDA presentation at J.P. Morgan be available after the event?

Yes. An archived link will remain on Vanda's website for approximately 30 days after the presentation.

What time should I join the J.P. Morgan event page for the VNDA presentation?

Investors are advised to arrive at the conference website at least 15 minutes early to register and install any required software.

Where on Vanda's site is the J.P. Morgan presentation located for VNDA investors?

Go to Vanda's corporate website, click the Investors tab, and select the link under Recent Events.

Is prior registration required to view Vanda's VNDA presentation at the conference?

Yes. Attendees should register on the conference website and complete any software downloads before the start time.